Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection

• Published in: Frontiers in immunology 2022-03, Vol.13, p.784463-784463
• Main Authors: Maruyama, Sandra Regina, Fuzo, Carlos Alessandro, Oliveira, Antonio Edson R, Rogerio, Luana Aparecida, Takamiya, Nayore Tamie, Pessenda, Gabriela, de Melo, Enaldo Vieira, da Silva, Angela Maria, Jesus, Amélia Ribeiro, Carregaro, Vanessa, Nakaya, Helder I, Almeida, Roque Pacheco, da Silva, João Santana
• Format: Article
• Language: English
• Subjects: blood transcriptomics; human visceral leishmaniasis; Humans; Immunology; Leishmania infantum (syn. Leishmania chagasi); Leishmania infantum - genetics; Leishmaniasis; Leishmaniasis, Visceral - genetics; long noncoding RNA–mRNA coexpression; mRNA sequencing (mRNA-seq); RNA, Long Noncoding - genetics; RNA, Messenger - genetics; Transcriptome
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2022.784463

Visceral leishmaniasis (VL) is a vector-borne infectious disease that can be potentially fatal if left untreated. In Brazil, it is caused by parasites. Blood transcriptomics allows us to assess the molecular mechanisms involved in the immunopathological processes of several clinical conditions, namely, parasitic diseases. Here, we performed mRNA sequencing of peripheral blood from patients with visceral leishmaniasis during the active phase of the disease and six months after successful treatment, when the patients were considered clinically cured. To strengthen the study, the RNA-seq data analysis included two other non-diseased groups composed of healthy uninfected volunteers and asymptomatic individuals. We identified thousands of differentially expressed genes between VL patients and non-diseased groups. Overall, pathway analysis corroborated the importance of signaling involving interferons, chemokines, Toll-like receptors and the neutrophil response. Cellular deconvolution of gene expression profiles was able to discriminate cellular subtypes, highlighting the contribution of plasma cells and NK cells in the course of the disease. Beyond the biological processes involved in the immunopathology of VL revealed by the expression of protein coding genes (PCGs), we observed a significant participation of long noncoding RNAs (lncRNAs) in our blood transcriptome dataset. Genome-wide analysis of lncRNAs expression in VL has never been performed. lncRNAs have been considered key regulators of disease progression, mainly in cancers; however, their pattern regulation may also help to understand the complexity and heterogeneity of host immune responses elicited by infections in humans. Among our findings, we identified lncRNAs such as IL21-AS1, MIR4435-2HG and LINC01501 and coexpressed lncRNA/mRNA pairs such as CA3-AS1/CA1, GASAL1/IFNG and LINC01127/IL1R1-IL1R2. Thus, for the first time, we present an integrated analysis of PCGs and lncRNAs by exploring the lncRNA-mRNA coexpression profile of VL to provide insights into the regulatory gene network involved in the development of this inflammatory and infectious disease.